NOBUAKI MORI

Dr. NOBUAKI MORI

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
NMNOBUAKI MORI
NOBUAKI MORI
SYSadako Yoshizawa
Sadako Yoshizawa
TSTomoo Saga
Tomoo Saga
YIYoshikazu Ishii
Yoshikazu Ishii
HMHinako Murakami
Hinako Murakami
KTKazuhiro Tateda
Kazuhiro Tateda

24 May 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
NMNOBUAKI MORI
NOBUAKI MORI
YIYoshikazu Ishii
Yoshikazu Ishii
KTKazuhiro Tateda
Kazuhiro Tateda
SKSoichiro Kimura
Soichiro Kimura
YKYuichi Kouyama
Yuichi Kouyama
EYEisaku Yoshihara
Eisaku Yoshihara
Objectives The β-barrel assembly machinery (BAM) complex plays a critical role in outer membrane protein (OMP) biogenesis. The outer membrane (OM) of Pseudomonas aeruginosa is centrally involved in mechanisms of antibiotic resistance. This study aimed to identify effects of a synthetic peptide based on conserved sequences in the putative BamA-binding region of BamD, focusing on antibiotic susceptibility and OMP characteristics in P. aeruginosa. Methods We synthesized a peptide FIRL (Phe-Ile-Arg-Leu-CONH2) with a sequence related to that of the BamD protein. We assessed antibiotic susceptibility of P. aeruginosa PAO1 using the chequerboard method and a time–kill assay. Changes in OMPs and in OM permeability were examined using SDS-PAGE, western blot analysis and nitrocefin assays. The combined effects of the peptide and antibiotics were investigated using a mouse pneumonia model. Results Although the peptide alone exerted no antimicrobial effect, it reduced the MICs of colistin, levofloxacin, erythromycin, vancomycin and rifampicin for P. aeruginosa PAO1 by 4-fold or more. Time–kill tests revealed bacterial numbers were significantly reduced after 2 h of incubation with the peptide plus colistin or levofloxacin. Moreover, in the presence of the peptide, expression of OprM was reduced by a third, and OM permeability was increased. The combination of the peptide (2.08 mg/kg) and colistin (1.25 mg/kg) significantly reduced P. aeruginosa by more than 1 log cfu/mL in a mouse pneumonia model. Conclusions We show, for the first time, that a synthetic peptide based on homologous sequences of BamD can potentiate antibiotic susceptibility of P. aeruginosa.

28 May 2018 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
NMNOBUAKI MORI
NOBUAKI MORI
TTTakashi Takahashi
Takashi Takahashi
Mori N, et al. Ann Lab Med. 2018 May;38(3):189-195. https://doi.org/10.3343/alm.2018.38.3.189


1 November 2011 in Physica C: Superconductivity and its Applications
Verified
Journal Article
Closed access
TMT. Maebatake
T. Maebatake
YIYuki Ichinose
Yuki Ichinose
KYK. Yamada
K. Yamada
NMNOBUAKI MORI
NOBUAKI MORI
RTRyo Teranishi
Ryo Teranishi
MMM. Mukaida
M. Mukaida

8 December 2017 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
NMNOBUAKI MORI
NOBUAKI MORI
YKYoshio Kamimura
Yoshio Kamimura
YKYuki Kimura
Yuki Kimura
SHShoko Hirose
Shoko Hirose
YAYasuko Aoki
Yasuko Aoki
SBSeiji Bito
Seiji Bito